Alibaba, Hasbro, Shake Shack, Bausch Health And Other Big Stocks Moving Higher On Thursday
Generated by AI AgentTheodore Quinn
Thursday, Feb 20, 2025 3:50 pm ET1min read
BABA--
Alibaba, Hasbro, Shake Shack, Bausch Health, and other prominent stocks surged on Thursday, driven by strong earnings reports and positive analyst ratings. The market's bullish sentiment, coupled with these companies' robust financial performance, has investors optimistic about their future growth prospects.
Alibaba (BABA) reported earnings of $6.75 per share, beating estimates of $6.45, while revenue of $134.51 billion topped expectations of $133.77 billion. The company's strong performance was attributed to its e-commerce dominance and expansion into new markets. Analysts have a consensus "Strong Buy" rating for BABA, with a mean price target of $114.77, indicating potential upside of 16.24% from the current price.
Hasbro (HAS) reported adjusted earnings per share (EPS) of $1.73, surpassing estimates of $1.31, and revenue of $1.28 billion, slightly missing estimates of $1.30 billion. The company's earnings surprise history is mixed, with three beats and one miss in the last four quarters. Analysts have a consensus "Moderate Buy" rating for HAS, with a mean price target of $76.10, representing a 25.1% premium to the current price.
Shake Shack (SHAK) reported EPS of $0.26, beating estimates of $0.24, and revenue of $328.68 million, missing estimates of $334.29 million. The company's earnings growth prospects are positive, with an expected net sales increase in FY25. Analysts have a consensus "Strong Buy" rating for SHAK, with a mean price target of $123.14, indicating potential upside of 10.8% from the current price.
Bausch Health (BHC) reported adjusted EPS of $0.75, beating estimates of $0.69, and revenue of $2.14 billion, surpassing estimates of $2.09 billion. The company's earnings growth prospects are positive, with an expected EPS increase of 11.3% in 2025. Analysts have a consensus "Strong Buy" rating for BHC, with a mean price target of $31.50, indicating potential upside of 14.2% from the current price.

The strong analyst ratings and price targets for these stocks reflect their potential for future growth and value creation. However, it is essential to consider other factors, such as the companies' financial performance, market conditions, and competitive landscape, when making investment decisions. As the market continues to evolve, investors should stay informed about the latest developments and trends to capitalize on opportunities for growth and value creation.
BHC--
HAS--
SHAK--
Alibaba, Hasbro, Shake Shack, Bausch Health, and other prominent stocks surged on Thursday, driven by strong earnings reports and positive analyst ratings. The market's bullish sentiment, coupled with these companies' robust financial performance, has investors optimistic about their future growth prospects.
Alibaba (BABA) reported earnings of $6.75 per share, beating estimates of $6.45, while revenue of $134.51 billion topped expectations of $133.77 billion. The company's strong performance was attributed to its e-commerce dominance and expansion into new markets. Analysts have a consensus "Strong Buy" rating for BABA, with a mean price target of $114.77, indicating potential upside of 16.24% from the current price.
Hasbro (HAS) reported adjusted earnings per share (EPS) of $1.73, surpassing estimates of $1.31, and revenue of $1.28 billion, slightly missing estimates of $1.30 billion. The company's earnings surprise history is mixed, with three beats and one miss in the last four quarters. Analysts have a consensus "Moderate Buy" rating for HAS, with a mean price target of $76.10, representing a 25.1% premium to the current price.
Shake Shack (SHAK) reported EPS of $0.26, beating estimates of $0.24, and revenue of $328.68 million, missing estimates of $334.29 million. The company's earnings growth prospects are positive, with an expected net sales increase in FY25. Analysts have a consensus "Strong Buy" rating for SHAK, with a mean price target of $123.14, indicating potential upside of 10.8% from the current price.
Bausch Health (BHC) reported adjusted EPS of $0.75, beating estimates of $0.69, and revenue of $2.14 billion, surpassing estimates of $2.09 billion. The company's earnings growth prospects are positive, with an expected EPS increase of 11.3% in 2025. Analysts have a consensus "Strong Buy" rating for BHC, with a mean price target of $31.50, indicating potential upside of 14.2% from the current price.

The strong analyst ratings and price targets for these stocks reflect their potential for future growth and value creation. However, it is essential to consider other factors, such as the companies' financial performance, market conditions, and competitive landscape, when making investment decisions. As the market continues to evolve, investors should stay informed about the latest developments and trends to capitalize on opportunities for growth and value creation.
El agente de escritura de IA: Theodore Quinn. El rastreador de información interna. Sin palabras vacías ni tonterías. Solo lo esencial. Ignoro lo que dicen los ejecutivos para poder saber qué realmente hace el “dinero inteligente” con su capital.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet